Group 1 - Instil Bio, Inc. (TIL) has seen a significant stock price increase of 108.2% over the past four weeks, closing at $26.75, with a mean price target of $118.67 indicating a potential upside of 343.6% [1] - The mean estimate includes three short-term price targets with a standard deviation of $64.73, where the lowest estimate of $51 suggests a 90.7% increase, and the most optimistic target is $180, indicating a potential surge of 572.9% [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 7.2% over the last 30 days [11][12] Group 2 - TIL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside in the near term [13] - While price targets are often viewed skeptically due to their historical inaccuracy, a tight clustering of targets with low standard deviation indicates a high degree of agreement among analysts regarding the stock's price direction [9][10] - The positive trend in earnings estimate revisions is a more reliable indicator of potential stock performance than price targets alone, as empirical research supports this correlation [11]
Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade